Hamid Erfanian's most recent trade in Enzo Biochem, Inc. was a trade of 300,000 Stock Option (to acquire Common Stock) done . Disclosure was reported to the exchange on Nov. 23, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enzo Biochem, Inc. | Hamid Erfanian | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 300,000 | 300,000 | - | - | Stock Option (to acquire Common Stock) | |
| Enzo Biochem, Inc. | Hamid Erfanian | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.97 per share. | 23 Nov 2022 | 100,000 | 374,600 (0%) | 0% | 2.0 | 197,000 | Common Stock, $0.01 Par Value |
| Enzo Biochem, Inc. | Hamid Erfanian | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 700,000 | 700,000 | - | - | Stock Option (to acquire Common Stock) | |
| Enzo Biochem, Inc. | Hamid Erfanian | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 15 Jun 2022 | 4,600 | 274,600 (0%) | 0% | 2.2 | 10,074 | Common Stock, $0.01 Par Value |
| Enzo Biochem, Inc. | Hamid Erfanian | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 700,000 | 700,000 | - | - | Stock Option (to acquire Common Stock) | |
| Enzo Biochem, Inc. | Hamid Erfanian | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 2.90 per share. | 13 Apr 2022 | 10,000 | 270,000 (0%) | 0% | 2.9 | 29,000 | Common Stock, $0.01 Par Value |
| Enzo Biochem, Inc. | Hamid Erfanian | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 700,000 | 700,000 | - | - | Stock Option (to acquire Common Stock) | |
| Enzo Biochem, Inc. | Hamid Erfanian | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 260,000 | 260,000 (0%) | 0% | 0 | Common Stock, $0.01 Par Value |